Eric Rey - Director, Arcadia Biosciences, Inc
As of June 4, 2019
Eric Rey Net Worth
- Net worth is estimated to be at least $1.41M
- Owns at least 7,335 units of Arcadia Biosciences, Inc stock
- Sold an estimated value of $1.22M in the last 4 years at Arcadia Biosciences, Inc
Eric Rey Trading
- Largest purchase of shares was 21,255 units , worth over $464.91K on March 16, 2018
- Largest sale of shares was 21,255 units , worth over $964.62K on March 16, 2018
- In total has made about 7 transactions over 4 years
- Usually trades in June, with the busiest year in 2018
Eric Rey
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Eric Rey Mailing Address
- Mailing address is Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 CA
Arcadia Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Matthew T. Plavan | 2020 | $370,000 | - | - | $325,642 | $98,506 | - | $794,148 |
| Matthew T. Plavan | 2019 | $321,538 | - | - | $105,040 | $154,500 | - | $581,078 |
| Pamela Haley | 2020 | $240,000 | - | - | $171,391 | $31,800 | - | $443,191 |
| Pamela Haley | 2019 | $212,671 | - | - | $16,564 | $55,800 | - | $285,035 |
| Randall Shultz | 2020 | $244,923 | $12,500 | - | $158,157 | $15,900 | - | $431,480 |
| Randall Shultz | 2019 | $160,096 | $12,500 | - | $85,500 | $39,200 | $42,268 | $339,564 |
| Sarah Reiter | 2020 | $210,972 | - | - | $214,241 | - | $101,942 | $527,155 |
| Sarah Reiter | 2019 | $268,840 | $12,500 | - | $94,152 | $80,900 | - | $456,392 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021019590/rkda-def14a_20210602.htm
Arcadia Biosciences, Inc Insider Trading
- The most recent transaction was 585 units bought on January 25, 2021 by Matthew Plavan worth over $1.85K
- In the last 5 years, insiders at Arcadia Biosciences, Inc sold an estimated value of $1.76M and bought an estimated value of $23.24M
- The most active traders are Eric Rey, Director, Matthew Plavan, Chief Executive Officer, and Kevin Comcowich, Director
- Insider trading is most common in June, with the busiest year in 2015
Arcadia Biosciences, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||